Azione USNU U.S. NEUROSURGICAL HOLDINGS, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue U.S. NeuroSurgical Holdings, Inc.

Azioni

USNU

US90336K1016

Mercato chiuso - OTC Markets
Altri mercati azionari
 16:48:07 28/06/2024 		Variaz. 5gg Var. 1 gen.
0,6625 USD 0,00% Grafico intraday di U.S. NeuroSurgical Holdings, Inc. +16,23% +47,22%
15/05 U.S. NeuroSurgical Holdings, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
05/04 U.S. NeuroSurgical Holdings, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
U.S. NEUROSURGICAL HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
U.S. NeuroSurgical Holdings, Inc. Appoints William St. Lawrence as a Non-Executive Director
U.S. NEUROSURGICAL HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NEUROSURGICAL HOLDINGS, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione USNU
  4. Notizie U.S. NeuroSurgical Holdings, Inc.
  5. Altre lingue